aica ribonucleotide and Rhabdomyosarcoma

aica ribonucleotide has been researched along with Rhabdomyosarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, Q; Hao, S; Qu, J; Wang, C; Yan, S; Zhou, D	1

Other Studies

1 other study(ies) available for aica ribonucleotide and Rhabdomyosarcoma

Article	Year
PFK15, a PFKFB3 antagonist, inhibits autophagy and proliferation in rhabdomyosarcoma cells. International journal of molecular medicine, 2018, Volume: 42, Issue:1 Topics: Adenylate Kinase; Aminoimidazole Carboxamide; Autophagy; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Clone Cells; Down-Regulation; Humans; Mechanistic Target of Rapamycin Complex 1; Phosphofructokinase-2; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyridines; Quinolines; Rhabdomyosarcoma; Ribonucleotides	2018

Article

Year

PFK15, a PFKFB3 antagonist, inhibits autophagy and proliferation in rhabdomyosarcoma cells.

International journal of molecular medicine, 2018, Volume: 42, Issue:1

Topics: Adenylate Kinase; Aminoimidazole Carboxamide; Autophagy; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Clone Cells; Down-Regulation; Humans; Mechanistic Target of Rapamycin Complex 1; Phosphofructokinase-2; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyridines; Quinolines; Rhabdomyosarcoma; Ribonucleotides

2018